Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)

O Sgarbura, C Eveno, M Alyami, N Bakrin… - Pleura and …, 2022 - degruyter.com
Objectives Safe implementation and thorough evaluation of new treatments require
prospective data monitoring and standardization of treatments. Pressurized intraperitoneal …

Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: A systematic review by the PIPAC UK collaborative

A Case, S Prosser, CJ Peters, R Adams… - Critical Reviews in …, 2022 - Elsevier
Introduction Gastric cancer with peritoneal metastases (GCPM) carries a poor prognosis.
Pressurised Intraperitoneal Aerosolised Chemotherapy (PIPAC) offers pharmacokinetic …

Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort

WJ Koemans, RJ Lurvink, C Grootscholten… - Gastric Cancer, 2021 - Springer
Introduction The peritoneum is a predilection site for gastric cancer metastases. Current
standard treatment for gastric cancer patients with synchronous peritoneal metastases is …

Feasibility and safety of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy with or without intraoperative intravenous 5-fluorouracil and leucovorin for …

A Taibi, O Sgarbura, M Hübner, SM Bardet… - Annals of Surgical …, 2022 - Springer
Background This retrospective multicenter cohort study compared the feasibility and safety
of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-Ox) with or …

Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: technical aspects and treatment protocols

M Hübner, M Alyami, L Villeneuve… - European Journal of …, 2022 - Elsevier
Background Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is increasingly used
to treat patients with peritoneal cancer. A recent survey demonstrated considerable …

Pressurized intraperitoneal aerosol chemotherapy enhanced by electrostatic precipitation (ePIPAC) for patients with peritoneal metastases

A Taibi, H Teixeira Farinha, S Durand Fontanier… - Annals of surgical …, 2021 - Springer
Background Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new mode of
intraperitoneal chemotherapy administration that can potentially be improved by the addition …

Response evaluation in patients with peritoneal metastasis treated with pressurized IntraPeritoneal aerosol chemotherapy (PIPAC)

S Roensholdt, S Detlefsen, MB Mortensen… - Journal of Clinical …, 2023 - mdpi.com
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) directed therapy emerged as a
treatment of peritoneal metastasis (PM) a decade ago. The response assessment of PIPAC …

Performance of different nebulizers in clinical use for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)

D Göhler, K Oelschlägel, M Ouaissi, U Giger-Pabst - Plos one, 2024 - journals.plos.org
Objective Technical ex-vivo comparison of commercial nebulizer nozzles used for
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Methods The performance of …

[HTML][HTML] The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a …

RJ Lurvink, K Van der Speeten, KP Rovers… - Journal of …, 2021 - ncbi.nlm.nih.gov
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an emerging palliative
treatment for patients with unresectable peritoneal metastases. Potential advantages of …

[HTML][HTML] How to Implement Pressurized Intraperitoneal Aerosol Chemotherapy into a National Health System Scenario: A Single-Center Retrospective Analysis of …

M Aulicino, C Orsini, G D'Annibale, L Barberis… - Cancers, 2024 - mdpi.com
Simple Summary Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new
surgical procedure used in the treatment of peritoneal surface malignancies (PSMs). Despite …